20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

Thunnissen, E., Lissenberg-Witte, B., van den Heuvel, M. M., Monkhorst, K., Skov, B. G., Sorensen, J. B., Mellemgaard, A., Dingemans, A. M. C., Speel, E. J. M., de Langen, A. J., Hashemi, S. M. S., Bahce, I., van der Drift, M. A., Looijen-Salamon, M. G., Gosney, J., Postmus, P. E., Samii, S. M. S., Duplaquet, F., Weynand, B., Durando, X. & 15 others, Penault-Llorca, F., Finn, S., Grady, A. O., Oz, B., Akyurek, N., Buettner, R., Wolf, J., Bubendorf, L., Duin, S., Marondel, L., Heukamp, L. C., Timens, W., Schuuring, E. M. D., Pauwels, P. & Smit, E. F., Dec 2019, In : Lung Cancer. 138, p. 13-18 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?

de Jong, E. E. C., Sanders, K. J. C., Deist, T. M., van Elmpt, W., Jochems, A., van Timmeren, J. E., Leijenaar, R. T. H., Degens, J. H. R. J., Schols, A. M. W. J., Dingemans, A. -M. C. & Lambin, P., Oct 2019, In : European Journal of Cancer. 120, p. 107-113 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Levy, A., Hendriks, L. E. L., Le Pechoux, C., Falk, S., Besse, B., Novello, S., Dingemans, A-M. C., Hasan, B., Reck, M., Berghmans, T. & Faivre-Finn, C., Oct 2019, In : Lung Cancer. 136, p. 145-147 3 p.

Research output: Contribution to journalArticleAcademicpeer-review